NEUROLIGN
LIVE

Serial Number

90021552

Owner

SPRYSON, INC.

Attorney

Thad Chaloemtiarana

Filing Date

Jun 25, 2020

Add to watchlist:

No watchlists yet
View on USPTO

NEUROLIGN Trademark

Serial Number: 90021552

NEUROLIGN is a trademark filed by SPRYSON, INC. on June 25, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 37 (Building & Construction), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

SPRYSON, INC.

651 N. BROAD STREET
MIDDLETOWN, DE 19709

Entity Type: 03

Spryson, Inc. (3 trademarks)

651 N. Broad Street, Suite 201
Middletown, DE 19709

Entity Type: 03

Trademark Details

Filing Date

June 25, 2020

Registration Date

Not Registered

Goods & Services

Computer software installation and maintenance; calibration of medical diagnostic apparatus and instruments; professional technical support services, namely, troubleshooting of computer software problems related to medical diagnostic apparatus and instruments; providing temporary use of non-downloadable computer software for the evaluation, diagnosis and treatment of vestibular and neurotologic disorders

Apparatus for performing oculographic analysis including video oculography, video nystagmography, and video frenzel systems; medical devices for diagnosing and measuring concussion; apparatus used in implementing diagnosis tests for vestibular and neurotologic disorders; medical device, namely, a head mounted display for evaluating, diagnosing and treating vestibular and neurotologic disorders; medical device, namely, a video screen, processor, and headset, provided together as a kit, for evaluating, diagnosing and treating vestibular and neurotologic disorders

Computer hardware and downloadable and recordable software for use in conducting and analyzing oculomotor, vestibular, reaction time and cognitive tests; computer hardware and downloadable and recordable software for capturing, tracking, processing and analyzing high speed digital images of the eye; downloadable software applications for mobile phones for use in diagnosing and measuring concussion

Installation, maintenance, diagnosis and repair of medical diagnostic apparatus and instruments

Pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, concussion, multiple sclerosis, dementia, mild cognitive impairment, Parkinson's disease, attention deficit hyperactivity disorder, Alzheimer's disease, strabismus and vestibular migraine; pharmaceutical preparations for the treatment of the symptoms of concussion; nutraceutical preparations for the treatment of neurological diseases and disorders, namely, concussion, multiple sclerosis, dementia, mild cognitive impairment, Parkinson's disease, attention deficit hyperactivity disorder, Alzheimer's disease, strabismus and vestibular migraine; nutraceutical preparations for the treatment of the symptoms of concussion

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 23, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 23, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 22, 2026 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 9, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 9, 2026 GNSL
SUSPENSION LETTER WRITTEN
Feb 9, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 9, 2026 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 14, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 14, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 14, 2026 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 8, 2025 RCCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 14, 2025 ASGN
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 7, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
May 7, 2025 GNSL
SUSPENSION LETTER WRITTEN
May 7, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 7, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 7, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 10, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Feb 10, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Feb 10, 2025 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 8, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 8, 2024 GNSL
SUSPENSION LETTER WRITTEN
Aug 8, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 8, 2024 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 7, 2024 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 30, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 30, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
May 30, 2024 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 10, 2024 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 9, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 9, 2023 GNSL
SUSPENSION LETTER WRITTEN
Nov 9, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 9, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 9, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 24, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 24, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 24, 2023 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 26, 2023 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 6, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 8, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 8, 2022 GNSL
SUSPENSION LETTER WRITTEN
Jun 8, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 8, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 8, 2022 CRFA
ASSIGNED TO LIE
Jun 8, 2022 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 7, 2022 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 13, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Dec 13, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Dec 13, 2021 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 12, 2021 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 11, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
May 11, 2021 GNSL
SUSPENSION LETTER WRITTEN
May 11, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 30, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 29, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 29, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 29, 2020 GNRN
NON-FINAL ACTION E-MAILED
Sep 29, 2020 GNRT
NON-FINAL ACTION WRITTEN
Sep 29, 2020 CNRT
ASSIGNED TO EXAMINER
Sep 27, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 23, 2020 NWOS
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jul 16, 2020 AMPX
ASSIGNED TO LIE
Jul 10, 2020 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Jun 30, 2020 PARI
NEW APPLICATION ENTERED
Jun 29, 2020 NWAP